Literature DB >> 15083763

A population-based study of the costs of care for community-acquired pneumonia.

M Bartolomé1, J Almirall, J Morera, G Pera, V Ortún, J Bassa, I Bolíbar, X Balanzó, A Verdaguer.   

Abstract

In a population-based study, the consumption of resources for treating adult patients with community-acquired pneumonia was determined. During a 2-yr period, all cases with a clinical and radiological suspicion of community-acquired pneumonia that occurred in patients aged > 14 yrs in a community of 74,610 inhabitants were investigated prospectively. Of 292 cases with a suspicion of community-acquired pneumonia, 224 were included (18.5% misdiagnoses). The mean number of visits per patient was 4.5 (72% in the primary care setting). Inpatient care was recommended in 59.8% of cases; after discharge, 44% of patients were managed in outpatient clinics. The mean direct cost of pneumonia treated in the hospital setting was [symbol: see text] (euros) 1,553, whereas the mean cost of cases treated as outpatients was [symbol: see text] 196. A total of 15.7% of admissions were considered inappropriate and the length of stay could have been reduced by 3.5 days in the most severe cases. A reduction in inappropriate admissions and lengths of hospital stay would result in a decrease in cost of 17.4%. Community-acquired pneumonia in Maresme, Spain, occurs at a low incidence, although with a high percentage of hospitalisations (in part inappropriate), resulting in considerable costs.

Entities:  

Mesh:

Year:  2004        PMID: 15083763     DOI: 10.1183/09031936.04.00076704

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  23 in total

1.  CURB-65 score predicted mortality in community-acquired pneumonia better than IDSA/ATS minor criteria in a low-mortality-rate setting.

Authors:  Q Guo; H-Y Li; Y-P Zhou; M Li; X-K Chen; H Liu; H-L Peng; H-Q Yu; X Chen; N Liu; L-H Liang; Q-Z Zhao; M Jiang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-07-18       Impact factor: 3.267

2.  Relationships among initial hospital triage, disease progression and mortality in community-acquired pneumonia.

Authors:  Samuel M Brown; Jason P Jones; Dominik Aronsky; Barbara E Jones; Michael J Lanspa; Nathan C Dean
Journal:  Respirology       Date:  2012-11       Impact factor: 6.424

Review 3.  Defining severe pneumonia.

Authors:  Samuel M Brown; Nathan C Dean
Journal:  Clin Chest Med       Date:  2011-07-12       Impact factor: 2.878

Review 4.  Defining and predicting severe community-acquired pneumonia.

Authors:  Samuel M Brown; Nathan C Dean
Journal:  Curr Opin Infect Dis       Date:  2010-04       Impact factor: 4.915

5.  Validation of the Infectious Disease Society of America/American Thoracic Society 2007 guidelines for severe community-acquired pneumonia.

Authors:  Samuel M Brown; Barbara E Jones; Al R Jephson; Nathan C Dean
Journal:  Crit Care Med       Date:  2009-12       Impact factor: 7.598

6.  Discharge Delay in Patients with Community-acquired Pneumonia Managed on a Critical Pathway.

Authors:  Jeremy J Moeller; Martin Ma; Paul Hernandez; Thomas Marrie; Claire Touchie; Ward Patrick
Journal:  Can J Infect Dis Med Microbiol       Date:  2006-03       Impact factor: 2.471

7.  External validation of the CURSI criteria (confusion, urea, respiratory rate and shock index) in adults hospitalised for community-acquired pneumonia.

Authors:  Harald Nüllmann; Marc Andre Pflug; Thomas Wesemann; Hans-Jürgen Heppner; Ludger Pientka; Ulrich Thiem
Journal:  BMC Infect Dis       Date:  2014-01-22       Impact factor: 3.090

8.  Retrospective epidemiological study for the characterization of community- acquired pneumonia and pneumococcal pneumonia in adults in a well-defined area of Badalona (Barcelona, Spain).

Authors:  Antoni Sicras-Mainar; Jordi Ibáñez-Nolla; Isabel Cifuentes; Pablo Guijarro; Ruth Navarro-Artieda; Lorenzo Aguilar
Journal:  BMC Infect Dis       Date:  2012-11-01       Impact factor: 3.090

9.  Comorbidities as a driver of the excess costs of community-acquired pneumonia in U.S. commercially-insured working age adults.

Authors:  Daniel Polsky; Machaon Bonafede; Jose A Suaya
Journal:  BMC Health Serv Res       Date:  2012-10-31       Impact factor: 2.655

10.  Budget impact analysis of a pneumococcal vaccination programme in the 65-year-old Spanish cohort using a dynamic model.

Authors:  Roberto Pradas; Angel Gil de Miguel; Alejandro Álvaro; Ruth Gil-Prieto; Reyes Lorente; Cristina Méndez; Pablo Guijarro; Fernando Antoñanzas
Journal:  BMC Infect Dis       Date:  2013-04-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.